Prevalence of group B streptococcus colonization in pregnant women in Jiangsu, East China

Yanmei Ge1, Fei Pan2, Rui Bai1, Yuan Mao2, Wenli Ji1, Fenfang Wang2, Huacheng Tong1
1Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China
2Nanjing Kingmed Center for Clinical Laboratory Co., Ltd, Nanjing, China

Tóm tắt

Group B streptococcus (GBS) is the leading cause of early-onset neonatal sepsis. However, GBS was infrequently reported in the developing world in contrast to western countries. This study assessed the prevalence of GBS colonization among pregnant women in Jiangsu, East China, and revealed the difference of GBS infection between culture and PCR. A total of 16,184 pregnant women at 34 to 37 weeks’ gestation aged 16–47 years were recruited from Nanjing Kingmed Center for Clinical Laboratory. Nine thousand twenty-two pregnant women received GBS screening by PCR detection only. Seven thousand one hundred sixty-two pregnant women received GBS screening by bacterial culture and GBS-positive samples were tested for antibiotic resistance. The overall GBS positive rate was 8.7% by PCR and 3.5% by culture. Colonization rate was highest in the “25–29 years” age group. The 249 GBS-positive samples which detected by culture were all sensitive to penicillin. The prevalence of resistance to erythromycin, clindamycin, and levofloxacin was 77.5, 68.3, and 52.2%, respectively. This study revealed the data on the prevalence of GBS colonization in pregnant women at 34 to 37 weeks’ gestation in Jiangsu, East China. It compared the difference of the sensitivity to detect GBS between PCR and culture. PCR was expected to become a quick method in pregnancy women conventional detection of GBS infection.

Từ khóa


Tài liệu tham khảo

Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36.

Edwards MS, Baker CJ. Streptococcus agalactiae (group B streptococcus). In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier/Saunders; 2015: 2340–2348.

Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al., editors. Williams obstetrics. 24nd ed. New York: McGraw-Hill Education/Medical; 2014:1249–51.

Schrag SJ, Schuchat A. Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. Clin Infect Dis. 2004;38(9):1209–11. https://doi.org/10.1086/382889.

Huang J, Lin X-Z, Zhu Y, Chen C. Epidemiology of group B streptococcal infection in pregnant women and diseased infants in mainland China. Pediatr Neonatol. 2019. https://doi.org/10.1016/j.pedneo.2019.07.001.

de Azavedo JC, McGavin M, Duncan C, Low DE, Mcgeep A. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother. 2001;45(12):3504–8. https://doi.org/10.1128/AAC.45.12.3504-3508.2001.

von Both U, Buerckstuemmer A, Fluegge K, Berner R. Heterogeneity of genotype-phenotype correlation among macrolide-resistant Streptococcus agalactiae isolates. Antimicrob Agents Chemother. 2005;49(7):3080–2. https://doi.org/10.1128/AAC.49.7.3080-3082.2005.

Chohan L, Hollier LM, Bishop K, Kilpatrick CC. Patterns of antibiotic resistance among group B Streptococcus isolates: 2001-2004. Infect Dis Obstet Gynecol. 2006;2006:57492.

Heelan JS, Hasenbein ME, McAdam AJ. Resistance of group B Streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol. 2004;42(3):1263–4. https://doi.org/10.1128/JCM.42.3.1263-1264.2004.

Chukwu MO, Mavenyengwa RT, Monyama CM, Bolukaoto JY, Lebelo SL, Maloba MRB, et al. Antigenic distribution of Streptococcus agalactiae isolates from pregnant women at Garankuwa hospital – South Africa. GERMS. 2015;5(4):125–33. https://doi.org/10.11599/germs.2015.1080.

Breeding KM, Ragipani B, Lee KD, et al. Real-time PCR-based serotyping of Streptococcus agalactiae. Sci Rep. 2016;6(1):38523. https://doi.org/10.1038/srep38523.

CLSI. Performance standards for antimicrobial susceptibility tests; approved standard, 12th ed. M100-S20-U. Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2010.

Di RG, Melin P, Berardi A, Blennow M, Carbonellestrany X, Donzelli GP, et al. Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Med. 2014;28:766–82.

Kwatra G, Cunnington MC, Merrall E, Adrian PV, Ip M, Klugman KP, et al. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(9):1076–84. https://doi.org/10.1016/S1473-3099(16)30055-X.

Hsu JF, Chen CL, Lee CC, Lien R, Chu SM, Fu RH, et al. Characterization of group B Streptococcus colonization in full-term and lete-preterm neonates in Taiwan. Pediatr Neonatol. 2018;S1875–9572(18):30059–7.

Lu B, Li D, Cui Y, Sui W, Huang L, Lu X. Epidemiology of group B streptococcus isolated from pregnant women in Beijing, China. Clin Microbiol Infect. 2014;20:370–3.

Wang X. The relation between maternal colonization of group B streptococcus in late pregnancy and the pregnancy outcome. J Baotou Med Coll. 2015;31:34–5.

Chen HH, Fan JX, Lu TY, Xu TY. Effect of group B streptococcus infection on pregnant women and their infants. Shanghai Med J. 2009;32:128–30.

Ji XQ, Lu GS, Hu P, Cheng J, Liu Y, Lin Y. Colonization of group B Streptococcus in late pregnancy by fluorescence quantitation PCR in Nanjing area. Lab Med. 2014;29:628–30.

He JW, Zhang Y, Chen M, Yuan Y, Fan C, Li QQ, et al. Effect of group B streptococcus infection on pregnant women of different reproductive ages in Chongqing. Int J Lab Med. 2016;37:2784–6.

Jidi AY, Ma J, Tong W, Xiao XL. Risk factors for group B streptococcus colonization among pregnant women and effectiveness of intrapartum antibiotic prophylaxis on maternal and newborn outcomes. J Clin Med Pract. 2017;21:194–6.

Atkins KL, Atkinson RM, Shanks A, Parvinn CA, Dunne WM, Gross G. Evaluation of polymerase chain reaction for group B streptococcus detection using an improved culture method. Obstetr Gynecol. 2006;108(3, Part 1):488–91.

Ostroff RM, Steaffens JW. Effect of specimen storage, antibiotics, and feminine hygiene products on the detection of group B Streptococcus by culture and the STREP B OIA test. Diagn Microbiol Infect Dis. 1995;22(3):253–9. https://doi.org/10.1016/0732-8893(95)00046-D.

Kaseman JA, Myers NM, Miracle JE, Myers JP. Group B streptococcal bacteremia in adults in the 21st century: review of 132 episodes over a 10-year period in a large community teaching hospital. Infect Dis Clin Pract. 2013;21(2):105–10. https://doi.org/10.1097/IPC.0b013e318279ee4f.

Wang YH, Su LH, Hou JN, Yang TH, Lin TY, Chu C, et al. Group B. streptococcal disease in nonpregnant patients: emergence of highly resistant strains of serotype Ib in Taiwan in 2006 to 2008. J Clin Microbiol. 2010;48(7):2571–4. https://doi.org/10.1128/JCM.00810-10.